These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35023356)

  • 1. Effect of Shared Decision-Making for Stroke Prevention on Treatment Adherence and Safety Outcomes in Patients With Atrial Fibrillation: A Randomized Clinical Trial.
    Noseworthy PA; Branda ME; Kunneman M; Hargraves IG; Sivly AL; Brito JP; Burnett B; Zeballos-Palacios C; Linzer M; Suzuki T; Lee AT; Gorr H; Jackson EA; Hess E; Brand-McCarthy SR; Shah ND; Montori VM;
    J Am Heart Assoc; 2022 Jan; 11(2):e023048. PubMed ID: 35023356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Shared Decision-making for Stroke Prevention in Patients With Atrial Fibrillation: A Randomized Clinical Trial.
    Kunneman M; Branda ME; Hargraves IG; Sivly AL; Lee AT; Gorr H; Burnett B; Suzuki T; Jackson EA; Hess E; Linzer M; Brand-McCarthy SR; Brito JP; Noseworthy PA; Montori VM;
    JAMA Intern Med; 2020 Sep; 180(9):1215-1224. PubMed ID: 32897386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shared decision making for stroke prevention in atrial fibrillation: study protocol for a randomized controlled trial.
    Kunneman M; Branda ME; Noseworthy PA; Linzer M; Burnett B; Dick S; Spencer-Bonilla G; Fernandez CA; Gorr H; Wambua M; Keune S; Zeballos-Palacios C; Hargraves I; Shah ND; Montori VM
    Trials; 2017 Sep; 18(1):443. PubMed ID: 28962662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized Clinical Trial to Evaluate an Atrial Fibrillation Stroke Prevention Shared Decision-Making Pathway.
    Wang PJ; Lu Y; Mahaffey KW; Lin A; Morin DP; Sears SF; Chung MK; Russo AM; Lin B; Piccini J; Hills MT; Berube C; Pundi K; Baykaner T; Garay G; Lhamo K; Rice E; Pourshams IA; Shah R; Newswanger P; DeSutter K; Nunes JC; Albert MA; Schulman KA; Heidenreich PA; Bunch TJ; Sanders LM; Turakhia M; Verghese A; Stafford RS
    J Am Heart Assoc; 2023 Feb; 12(3):e028562. PubMed ID: 36342828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel shared decision-making (SDM) tool for anticoagulation management in atrial fibrillation: protocol for a prospective, cluster randomized controlled trial.
    Pan MM; Zhang C; Shen L; Sha JJ; Shen H; Yan YD; Wang J; Wang X; Lin HW; Gu ZC
    Trials; 2023 Oct; 24(1):623. PubMed ID: 37779187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of a conversation tool to promote shared decision making about anticoagulation in patients with atrial fibrillation within a practical randomized trial of its effectiveness: a cross-sectional study.
    Spencer-Bonilla G; Thota A; Organick P; Ponce OJ; Kunneman M; Giblon R; Branda ME; Sivly AL; Behnken E; May CR; Montori VM;
    Trials; 2020 May; 21(1):395. PubMed ID: 32398149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ENHANCE-AF clinical trial to evaluate an atrial fibrillation shared decision-making pathway: Rationale and study design.
    Baykaner T; Pundi K; Lin B; Lu Y; DeSutter K; Lhamo K; Garay G; Nunes JC; Morin DP; Sears SF; Chung MK; Paasche-Orlow MK; Sanders LM; Bunch TJ; Hills MT; Mahaffey KW; Stafford RS; Wang PJ
    Am Heart J; 2022 May; 247():68-75. PubMed ID: 35092723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized evaluation of decision support interventions for atrial fibrillation: Rationale and design of the RED-AF study.
    Jones AE; McCarty MM; Brito JP; Noseworthy PA; Cavanaugh KL; Cameron KA; Barnes GD; Steinberg BA; Witt DM; Crossley GH; Passman R; Kansal P; Hargraves I; Schmidt M; Jackson E; Guzman A; Ariotti A; Pershing ML; Herrick J; Montori VM; Fagerlin A; Ozanne EM;
    Am Heart J; 2022 Jun; 248():42-52. PubMed ID: 35218727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
    Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal timing of anticoagulation after acute ischemic stroke with atrial fibrillation (OPTIMAS): Protocol for a randomized controlled trial.
    Best JG; Arram L; Ahmed N; Balogun M; Bennett K; Bordea E; Campos MG; Caverly E; Chau M; Cohen H; Dehbi HM; Doré CJ; Engelter ST; Fenner R; Freemantle N; Hunter R; James M; Lip GY; Murray ML; Norrving B; Sprigg N; Veltkamp R; Zaczyk I; Werring DJ;
    Int J Stroke; 2022 Jun; 17(5):583-589. PubMed ID: 35018878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation.
    Stam-Slob MC; Connolly SJ; van der Graaf Y; van der Leeuw J; Dorresteijn JAN; Eikelboom JW; Peters RJG; Alings M; Visseren FLJ
    Circulation; 2019 Jun; 139(25):2846-2856. PubMed ID: 31046423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.
    Hohnloser SH; Fudim M; Alexander JH; Wojdyla DM; Ezekowitz JA; Hanna M; Atar D; Hijazi Z; Bahit MC; Al-Khatib SM; Lopez-Sendon JL; Wallentin L; Granger CB; Lopes RD
    Circulation; 2019 May; 139(20):2292-2300. PubMed ID: 30773022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).
    Sherwood MW; Douketis JD; Patel MR; Piccini JP; Hellkamp AS; Lokhnygina Y; Spyropoulos AC; Hankey GJ; Singer DE; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Becker RC;
    Circulation; 2014 May; 129(18):1850-9. PubMed ID: 24552831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) study.
    Arihiro S; Todo K; Koga M; Furui E; Kinoshita N; Kimura K; Yamagami H; Terasaki T; Yoshimura S; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Nagakane Y; Kameda T; Hasegawa Y; Shibuya S; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Matsuki T; Homma K; Takasugi J; Tokunaga K; Sato S; Kario K; Kitazono T; Toyoda K;
    Int J Stroke; 2016 Jul; 11(5):565-74. PubMed ID: 26927811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared Decision Making Tools for People Facing Stroke Prevention Strategies in Atrial Fibrillation: A Systematic Review and Environmental Scan.
    Torres Roldan VD; Brand-McCarthy SR; Ponce OJ; Belluzzo T; Urtecho M; Espinoza Suarez NR; Toloza FJK; Thota AD; Organick PW; Barrera F; Liu-Sanchez C; Jaladi S; Prokop L; Ozanne EM; Fagerlin A; Hargraves IG; Noseworthy PA; Montori VM; Brito JP
    Med Decis Making; 2021 Jul; 41(5):540-549. PubMed ID: 33896270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48.
    Giugliano RP; Ruff CT; Rost NS; Silverman S; Wiviott SD; Lowe C; Deenadayalu N; Murphy SA; Grip LT; Betcher JM; Duggal A; Dave J; Shi M; Mercuri M; Antman EM; Braunwald E;
    Stroke; 2014 Aug; 45(8):2372-8. PubMed ID: 24947287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-creating sensible care plans using shared decision making: Patients' reflections and observations of encounters.
    Kunneman M; Hargraves IG; Sivly AL; Branda ME; LaVecchia CM; Labrie NHM; Brand-McCarthy S; Montori V
    Patient Educ Couns; 2022 Jun; 105(6):1539-1544. PubMed ID: 34711446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk/Benefit Tradeoff of Antithrombotic Therapy in Patients With Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS.
    Alexander JH; Wojdyla D; Vora AN; Thomas L; Granger CB; Goodman SG; Aronson R; Windecker S; Mehran R; Lopes RD
    Circulation; 2020 May; 141(20):1618-1627. PubMed ID: 32223444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a shared decision-making tool to assist patients and clinicians with decisions on oral anticoagulant treatment for atrial fibrillation.
    Kaiser K; Cheng WY; Jensen S; Clayman ML; Thappa A; Schwiep F; Chawla A; Goldberger JJ; Col N; Schein J
    Curr Med Res Opin; 2015 Dec; 31(12):2261-72. PubMed ID: 26390360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation.
    Chiu HH; Chang SL; Cheng HM; Chao TF; Lin YJ; Lo LW; Hu YF; Chung FP; Liao JN; Tuan TC; Lin CY; Chang TY; Kuo L; Liu CM; Tsai YN; Huang YT; Chang YL; Wung JC; Chen SA
    BMC Med Inform Decis Mak; 2023 Aug; 23(1):163. PubMed ID: 37608374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.